A bill to provide for a period of exclusivity for first interchangeable biological products.
Interchangeable Biologics Clarity Act
This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line